Skip to main content

New Product Watch: Apr 19, 2010

Premium

Affymetrix this week launched its MIP Copy Number Service through its research services laboratory.

The service is run on the company's MIP 330K Cancer Panel and enables researchers to obtain high-quality, allele-specific copy number data from formalin-fixed, paraffin-embedded samples.

According to the firm, the availability of allele and copy number data on a single platform provides a comprehensive tool to evaluate risk factors for the early stages of cancer and disease relapse.


Gentel Biosciences has launched APiX View Detection Kits for chromogenic detection of protein microarrays, including reverse-phase protein chips such as Protein Biotechnologies' SomaPlex arrays.

APiX chromogenic technology allows for the detection of any biotinylated molecule, generating light grey-to-black spots that are visible to the eye and can be scanned with the Gentel Proteomics Multi-System, the firm said.

Gentel said the new kits expand the application of its APiX technology to include not only antibody and protein arrays on clear glass slides, but also tumor lysate arrays on porous nitrocellulose surfaces. Protein Biotechnologies said in a statement that the new kits could be used together with its arrays.


Roche NimbleGen said last week that it will now offer 2-micron resolution scanning on its MS 200 Microarray Scanner for its comparative genomic hybridization and gene expression arrays. The service upgrade is available through Roche NimbleGen's services facility in Reykjavik, Iceland, or via one of its certified service providers, the firm said.


Ariadne has released Pathway Studio Explore to help users visualize pathways for data obtained using the Affymetrix GeneAtlas microarray system.

Pathway Studio Explore helps researchers build and study protein interaction networks and perform network analysis of experimental data, according to Ariadne. The software also offers a data analysis and visualization tool.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.